Home > > > Report Detail

Global Nucleic Acid-based Therapeutics Market Size, Status and Forecast 2019-2025

Publisher Name :
Date: 16-Jul-2019
No. of pages: 99
Inquire Before Buying

Gene therapy is a technique for correcting defective genes responsible for disease development. Nucleic acid-based molecules (deoxyribonucleic acid, complementary deoxyribonucleic acid, complete genes, ribonucleic acid, and oligonucleotides) are utilized as research tools within the broad borders of gene therapy and the emerging field of molecular medicine.

Although most of the nucleic acid-based drugs are in early stages of clinical trials, these classes of compounds have emerged in recent years to yield extremely promising candidates for drug therapy to a wide range of diseases, including cancer, infectious diseases, diabetes, cardiovascular, inflammatory, and neurodegenerative diseases, cystic fibrosis, hemophilia, and other genetic disorders.

In 2018, the global Nucleic Acid-based Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Nucleic Acid-based Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Nucleic Acid-based Therapeutics development in United States, Europe and China.

The key players covered in this study

- Wave Life Sciences

- Imugene

- Caperna

- Phylogica

- Protagonist Therapeutics

- Benitec Biopharma

- EGEN

- BioMedica

- Transgene

- Copernicus Therapeutics

Market segment by Type, the product can be split into

- Anti-Sense And Anti-Gene

- Short Inhibitory Sequences

- Gene Transfer Therapy

- Nucleoside Analogs

- Ribozymes

- Aptamers

Market segment by Application, split into

- Monogenetic Disorders

- Multi-Genetic Disorders

Market segment by Regions/Countries, this report covers

- United States

- Europe

- China

- Japan

- Southeast Asia

- India

- Central & South America

The study objectives of this report are:

- To analyze global Nucleic Acid-based Therapeutics status, future forecast, growth opportunity, key market and key players.

- To present the Nucleic Acid-based Therapeutics development in United States, Europe and China.

- To strategically profile the key players and comprehensively analyze their development plan and strategies.

- To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Nucleic Acid-based Therapeutics are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global Nucleic Acid-based Therapeutics Market Size, Status and Forecast 2019-2025

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Nucleic Acid-based Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Anti-Sense And Anti-Gene
1.4.3 Short Inhibitory Sequences
1.4.4 Gene Transfer Therapy
1.4.5 Nucleoside Analogs
1.4.6 Ribozymes
1.4.7 Aptamers
1.5 Market by Application
1.5.1 Global Nucleic Acid-based Therapeutics Market Share by Application (2014-2025)
1.5.2 Monogenetic Disorders
1.5.3 Multi-Genetic Disorders
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Nucleic Acid-based Therapeutics Market Size
2.2 Nucleic Acid-based Therapeutics Growth Trends by Regions
2.2.1 Nucleic Acid-based Therapeutics Market Size by Regions (2014-2025)
2.2.2 Nucleic Acid-based Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Nucleic Acid-based Therapeutics Market Size by Manufacturers
3.1.1 Global Nucleic Acid-based Therapeutics Revenue by Manufacturers (2014-2019)
3.1.2 Global Nucleic Acid-based Therapeutics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Nucleic Acid-based Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Nucleic Acid-based Therapeutics Key Players Head office and Area Served
3.3 Key Players Nucleic Acid-based Therapeutics Product/Solution/Service
3.4 Date of Enter into Nucleic Acid-based Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Nucleic Acid-based Therapeutics Market Size by Type (2014-2019)
4.2 Global Nucleic Acid-based Therapeutics Market Size by Application (2014-2019)
5 United States
5.1 United States Nucleic Acid-based Therapeutics Market Size (2014-2019)
5.2 Nucleic Acid-based Therapeutics Key Players in United States
5.3 United States Nucleic Acid-based Therapeutics Market Size by Type
5.4 United States Nucleic Acid-based Therapeutics Market Size by Application
6 Europe
6.1 Europe Nucleic Acid-based Therapeutics Market Size (2014-2019)
6.2 Nucleic Acid-based Therapeutics Key Players in Europe
6.3 Europe Nucleic Acid-based Therapeutics Market Size by Type
6.4 Europe Nucleic Acid-based Therapeutics Market Size by Application
7 China
7.1 China Nucleic Acid-based Therapeutics Market Size (2014-2019)
7.2 Nucleic Acid-based Therapeutics Key Players in China
7.3 China Nucleic Acid-based Therapeutics Market Size by Type
7.4 China Nucleic Acid-based Therapeutics Market Size by Application
8 Japan
8.1 Japan Nucleic Acid-based Therapeutics Market Size (2014-2019)
8.2 Nucleic Acid-based Therapeutics Key Players in Japan
8.3 Japan Nucleic Acid-based Therapeutics Market Size by Type
8.4 Japan Nucleic Acid-based Therapeutics Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Nucleic Acid-based Therapeutics Market Size (2014-2019)
9.2 Nucleic Acid-based Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Nucleic Acid-based Therapeutics Market Size by Type
9.4 Southeast Asia Nucleic Acid-based Therapeutics Market Size by Application
10 India
10.1 India Nucleic Acid-based Therapeutics Market Size (2014-2019)
10.2 Nucleic Acid-based Therapeutics Key Players in India
10.3 India Nucleic Acid-based Therapeutics Market Size by Type
10.4 India Nucleic Acid-based Therapeutics Market Size by Application
11 Central & South America
11.1 Central & South America Nucleic Acid-based Therapeutics Market Size (2014-2019)
11.2 Nucleic Acid-based Therapeutics Key Players in Central & South America
11.3 Central & South America Nucleic Acid-based Therapeutics Market Size by Type
11.4 Central & South America Nucleic Acid-based Therapeutics Market Size by Application
12 International Players Profiles
12.1 Wave Life Sciences
12.1.1 Wave Life Sciences Company Details
12.1.2 Company Description and Business Overview
12.1.3 Nucleic Acid-based Therapeutics Introduction
12.1.4 Wave Life Sciences Revenue in Nucleic Acid-based Therapeutics Business (2014-2019)
12.1.5 Wave Life Sciences Recent Development
12.2 Imugene
12.2.1 Imugene Company Details
12.2.2 Company Description and Business Overview
12.2.3 Nucleic Acid-based Therapeutics Introduction
12.2.4 Imugene Revenue in Nucleic Acid-based Therapeutics Business (2014-2019)
12.2.5 Imugene Recent Development
12.3 Caperna
12.3.1 Caperna Company Details
12.3.2 Company Description and Business Overview
12.3.3 Nucleic Acid-based Therapeutics Introduction
12.3.4 Caperna Revenue in Nucleic Acid-based Therapeutics Business (2014-2019)
12.3.5 Caperna Recent Development
12.4 Phylogica
12.4.1 Phylogica Company Details
12.4.2 Company Description and Business Overview
12.4.3 Nucleic Acid-based Therapeutics Introduction
12.4.4 Phylogica Revenue in Nucleic Acid-based Therapeutics Business (2014-2019)
12.4.5 Phylogica Recent Development
12.5 Protagonist Therapeutics
12.5.1 Protagonist Therapeutics Company Details
12.5.2 Company Description and Business Overview
12.5.3 Nucleic Acid-based Therapeutics Introduction
12.5.4 Protagonist Therapeutics Revenue in Nucleic Acid-based Therapeutics Business (2014-2019)
12.5.5 Protagonist Therapeutics Recent Development
12.6 Benitec Biopharma
12.6.1 Benitec Biopharma Company Details
12.6.2 Company Description and Business Overview
12.6.3 Nucleic Acid-based Therapeutics Introduction
12.6.4 Benitec Biopharma Revenue in Nucleic Acid-based Therapeutics Business (2014-2019)
12.6.5 Benitec Biopharma Recent Development
12.7 EGEN
12.7.1 EGEN Company Details
12.7.2 Company Description and Business Overview
12.7.3 Nucleic Acid-based Therapeutics Introduction
12.7.4 EGEN Revenue in Nucleic Acid-based Therapeutics Business (2014-2019)
12.7.5 EGEN Recent Development
12.8 BioMedica
12.8.1 BioMedica Company Details
12.8.2 Company Description and Business Overview
12.8.3 Nucleic Acid-based Therapeutics Introduction
12.8.4 BioMedica Revenue in Nucleic Acid-based Therapeutics Business (2014-2019)
12.8.5 BioMedica Recent Development
12.9 Transgene
12.9.1 Transgene Company Details
12.9.2 Company Description and Business Overview
12.9.3 Nucleic Acid-based Therapeutics Introduction
12.9.4 Transgene Revenue in Nucleic Acid-based Therapeutics Business (2014-2019)
12.9.5 Transgene Recent Development
12.10 Copernicus Therapeutics
12.10.1 Copernicus Therapeutics Company Details
12.10.2 Company Description and Business Overview
12.10.3 Nucleic Acid-based Therapeutics Introduction
12.10.4 Copernicus Therapeutics Revenue in Nucleic Acid-based Therapeutics Business (2014-2019)
12.10.5 Copernicus Therapeutics Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
List of Tables and Figures
Table Nucleic Acid-based Therapeutics Key Market Segments
Table Key Players Nucleic Acid-based Therapeutics Covered
Table Global Nucleic Acid-based Therapeutics Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Nucleic Acid-based Therapeutics Market Size Market Share by Type 2014-2025
Figure Anti-Sense And Anti-Gene Figures
Table Key Players of Anti-Sense And Anti-Gene
Figure Short Inhibitory Sequences Figures
Table Key Players of Short Inhibitory Sequences
Figure Gene Transfer Therapy Figures
Table Key Players of Gene Transfer Therapy
Figure Nucleoside Analogs Figures
Table Key Players of Nucleoside Analogs
Figure Ribozymes Figures
Table Key Players of Ribozymes
Figure Aptamers Figures
Table Key Players of Aptamers
Table Global Nucleic Acid-based Therapeutics Market Size Growth by Application 2014-2025 (Million US$)
Figure Monogenetic Disorders Case Studies
Figure Multi-Genetic Disorders Case Studies
Figure Nucleic Acid-based Therapeutics Report Years Considered
Table Global Nucleic Acid-based Therapeutics Market Size 2014-2025 (Million US$)
Figure Global Nucleic Acid-based Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Nucleic Acid-based Therapeutics Market Size by Regions 2014-2025 (Million US$)
Table Global Nucleic Acid-based Therapeutics Market Size by Regions 2014-2019 (Million US$)
Table Global Nucleic Acid-based Therapeutics Market Share by Regions 2014-2019
Figure Global Nucleic Acid-based Therapeutics Market Share by Regions 2014-2019
Figure Global Nucleic Acid-based Therapeutics Market Share by Regions 2019
Table Market Top Trends
Table Global Nucleic Acid-based Therapeutics Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Nucleic Acid-based Therapeutics Market Share by Manufacturers (2014-2019)
Figure Global Nucleic Acid-based Therapeutics Market Share by Manufacturers in 2018
Table Global Nucleic Acid-based Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Nucleic Acid-based Therapeutics Product/Solution/Service
Table Date of Enter into Nucleic Acid-based Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Nucleic Acid-based Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Global Nucleic Acid-based Therapeutics Market Size Share by Type (2014-2019)
Figure Global Nucleic Acid-based Therapeutics Market Size Market Share by Type (2014-2019)
Table Global Nucleic Acid-based Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Global Nucleic Acid-based Therapeutics Market Size Share by Application (2014-2019)
Figure Global Nucleic Acid-based Therapeutics Market Size Market Share by Application (2014-2019)
Figure Global Nucleic Acid-based Therapeutics Revenue Market Share by Application in 2018
Figure United States Nucleic Acid-based Therapeutics Market Size 2014-2019 (Million US$)
Table United States Key Players Nucleic Acid-based Therapeutics Revenue (2018-2019) (Million US$)
Table United States Key Players Nucleic Acid-based Therapeutics Market Share (2018-2019)
Table United States Nucleic Acid-based Therapeutics Market Size by Type (2014-2019) (Million US$)
Table United States Nucleic Acid-based Therapeutics Market Share by Type (2014-2019)
Table United States Nucleic Acid-based Therapeutics Market Size by Application (2014-2019) (Million US$)
Table United States Nucleic Acid-based Therapeutics Market Share by Application (2014-2019)
Figure Europe Nucleic Acid-based Therapeutics Market Size 2014-2019 (Million US$)
Table Europe Key Players Nucleic Acid-based Therapeutics Revenue (2018-2019) (Million US$)
Table Europe Key Players Nucleic Acid-based Therapeutics Market Share (2018-2019)
Table Europe Nucleic Acid-based Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Europe Nucleic Acid-based Therapeutics Market Share by Type (2014-2019)
Table Europe Nucleic Acid-based Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Europe Nucleic Acid-based Therapeutics Market Share by Application (2014-2019)
Figure China Nucleic Acid-based Therapeutics Market Size 2014-2019 (Million US$)
Table China Key Players Nucleic Acid-based Therapeutics Revenue (2018-2019) (Million US$)
Table China Key Players Nucleic Acid-based Therapeutics Market Share (2018-2019)
Table China Nucleic Acid-based Therapeutics Market Size by Type (2014-20189) (Million US$)
Table China Nucleic Acid-based Therapeutics Market Share by Type (2014-2019)
Table China Nucleic Acid-based Therapeutics Market Size by Application (2014-2019) (Million US$)
Table China Nucleic Acid-based Therapeutics Market Share by Application (2014-2019)
Figure Japan Nucleic Acid-based Therapeutics Market Size 2014-2019 (Million US$)
Table Japan Key Players Nucleic Acid-based Therapeutics Revenue (2018-2019) (Million US$)
Table Japan Key Players Nucleic Acid-based Therapeutics Market Share (2018-2019)
Table Japan Nucleic Acid-based Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Japan Nucleic Acid-based Therapeutics Market Share by Type (2014-2019)
Table Japan Nucleic Acid-based Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Japan Nucleic Acid-based Therapeutics Market Share by Application (2014-2019)
Figure Southeast Asia Nucleic Acid-based Therapeutics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Nucleic Acid-based Therapeutics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Nucleic Acid-based Therapeutics Market Share (2018-2019)
Table Southeast Asia Nucleic Acid-based Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Nucleic Acid-based Therapeutics Market Share by Type (2014-2019)
Table Southeast Asia Nucleic Acid-based Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Nucleic Acid-based Therapeutics Market Share by Application (2014-2019)
Figure India Nucleic Acid-based Therapeutics Market Size 2014-2019 (Million US$)
Table India Key Players Nucleic Acid-based Therapeutics Revenue (2018-2019) (Million US$)
Table India Key Players Nucleic Acid-based Therapeutics Market Share (2018-2019)
Table India Nucleic Acid-based Therapeutics Market Size by Type (2014-2019) (Million US$)
Table India Nucleic Acid-based Therapeutics Market Share by Type (2014-2019)
Table India Nucleic Acid-based Therapeutics Market Size by Application (2014-2019) (Million US$)
Table India Nucleic Acid-based Therapeutics Market Share by Application (2014-2019)
Figure Central & South America Nucleic Acid-based Therapeutics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Nucleic Acid-based Therapeutics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Nucleic Acid-based Therapeutics Market Share (2018-2019)
Table Central & South America Nucleic Acid-based Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Central & South America Nucleic Acid-based Therapeutics Market Share by Type (2014-2019)
Table Central & South America Nucleic Acid-based Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Central & South America Nucleic Acid-based Therapeutics Market Share by Application (2014-2019)
Table Wave Life Sciences Company Details
Table Wave Life Sciences Revenue in Nucleic Acid-based Therapeutics Business (2014-2019) (Million US$)
Figure Wave Life Sciences Revenue Growth Rate in Nucleic Acid-based Therapeutics Business (2014-2019)
Table Wave Life Sciences Recent Development
Table Imugene Company Details
Table Imugene Revenue in Nucleic Acid-based Therapeutics Business (2014-2019)(Million US$)
Figure Imugene Revenue Growth Rate in Nucleic Acid-based Therapeutics Business (2014-2019)
Table Imugene Recent Development
Table Caperna Company Details
Table Caperna Revenue in Nucleic Acid-based Therapeutics Business (2014-2019)(Million US$)
Figure Caperna Revenue Growth Rate in Nucleic Acid-based Therapeutics Business (2014-2019)
Table Caperna Recent Development
Table Phylogica Company Details
Table Phylogica Revenue in Nucleic Acid-based Therapeutics Business (2014-2019)(Million US$)
Figure Phylogica Revenue Growth Rate in Nucleic Acid-based Therapeutics Business (2014-2019)
Table Phylogica Recent Development
Table Protagonist Therapeutics Company Details
Table Protagonist Therapeutics Revenue in Nucleic Acid-based Therapeutics Business (2014-2019)(Million US$)
Figure Protagonist Therapeutics Revenue Growth Rate in Nucleic Acid-based Therapeutics Business (2014-2019)
Table Protagonist Therapeutics Recent Development
Table Benitec Biopharma Company Details
Table Benitec Biopharma Revenue in Nucleic Acid-based Therapeutics Business (2014-2019)(Million US$)
Figure Benitec Biopharma Revenue Growth Rate in Nucleic Acid-based Therapeutics Business (2014-2019)
Table Benitec Biopharma Recent Development
Table EGEN Company Details
Table EGEN Revenue in Nucleic Acid-based Therapeutics Business (2014-2019)(Million US$)
Figure EGEN Revenue Growth Rate in Nucleic Acid-based Therapeutics Business (2014-2019)
Table EGEN Recent Development
Table BioMedica Company Details
Table BioMedica Revenue in Nucleic Acid-based Therapeutics Business (2014-2019)(Million US$)
Figure BioMedica Revenue Growth Rate in Nucleic Acid-based Therapeutics Business (2014-2019)
Table BioMedica Recent Development
Table Transgene Company Details
Table Transgene Revenue in Nucleic Acid-based Therapeutics Business (2014-2019)(Million US$)
Figure Transgene Revenue Growth Rate in Nucleic Acid-based Therapeutics Business (2014-2019)
Table Transgene Recent Development
Table Copernicus Therapeutics Company Details
Table Copernicus Therapeutics Revenue in Nucleic Acid-based Therapeutics Business (2014-2019)(Million US$)
Figure Copernicus Therapeutics Revenue Growth Rate in Nucleic Acid-based Therapeutics Business (2014-2019)
Table Copernicus Therapeutics Recent Development
Table Global Nucleic Acid-based Therapeutics Market Size by Regions (Million US$) 2019-2025
Figure Global Nucleic Acid-based Therapeutics Market Size Share by Regions (2019-2025)
Figure Global Nucleic Acid-based Therapeutics Market Size Share by Regions in 2025
Figure United States Nucleic Acid-based Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Nucleic Acid-based Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure China Nucleic Acid-based Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Nucleic Acid-based Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Nucleic Acid-based Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure India Nucleic Acid-based Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Nucleic Acid-based Therapeutics Market Size Forecast (2019-2025)(Million USD)
Table Global Nucleic Acid-based Therapeutics Market Size by Product (2019-2025) (Million US$)
Figure Global Nucleic Acid-based Therapeutics Market Size by Product (2019-2025)
Figure Global Nucleic Acid-based Therapeutics Market Size by Product in 2025
Table Global Nucleic Acid-based Therapeutics Market Size by Application (2019-2025) (Million US$)
Figure Global Nucleic Acid-based Therapeutics Market Size by Application (2019-2025)
Figure Global Nucleic Acid-based Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs